These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33681649)

  • 1. Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.
    Koh S; Wirrell E; Vezzani A; Nabbout R; Muscal E; Kaliakatsos M; Wickström R; Riviello JJ; Brunklaus A; Payne E; Valentin A; Wells E; Carpenter JL; Lee K; Lai YC; Eschbach K; Press CA; Gorman M; Stredny CM; Roche W; Mangum T
    Epilepsia Open; 2021 Mar; 6(1):62-72. PubMed ID: 33681649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives.
    Gaspard N; Hirsch LJ; Sculier C; Loddenkemper T; van Baalen A; Lancrenon J; Emmery M; Specchio N; Farias-Moeller R; Wong N; Nabbout R
    Epilepsia; 2018 Apr; 59(4):745-752. PubMed ID: 29476535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of febrile infection-related epilepsy syndrome (FIRES) in young adult: still a diagnostic and therapeutic challenge.
    Acampora R; Quiroga Subirana P; Durante L; Tonziello R; Aversano G; Lieto M; Ripa P; Mazzaferro MP
    Neurol Sci; 2022 Jul; 43(7):4555-4558. PubMed ID: 35507191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
    Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
    Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febrile Infection-Related Epilepsy Syndrome (FIRES): A Literature Review and Case Study.
    Fox K; Wells ME; Tennison M; Vaughn B
    Neurodiagn J; 2017; 57(3):224-233. PubMed ID: 28898171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective?
    Bonardi CM; Furlanis GM; Toldo I; Guarrera B; Luisi C; Pettenazzo A; Nosadini M; Boniver C; Sartori S; Landi A
    Brain Dev; 2023 May; 45(5):293-299. PubMed ID: 36725381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile infection-related Epilepsy Syndrome (FIRES): a severe encephalopathy with status epilepticus. Literature review and presentation of two new cases.
    Pavone P; Corsello G; Raucci U; Lubrano R; Parano E; Ruggieri M; Greco F; Marino S; Falsaperla R
    Ital J Pediatr; 2022 Dec; 48(1):199. PubMed ID: 36527084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
    Hon KL; Leung AKC; Torres AR
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
    Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult.
    Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A
    Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anakinra usage in febrile infection related epilepsy syndrome: an international cohort.
    Lai YC; Muscal E; Wells E; Shukla N; Eschbach K; Hyeong Lee K; Kaliakatsos M; Desai N; Wickström R; Viri M; Freri E; Granata T; Nangia S; Dilena R; Brunklaus A; Wainwright MS; Gorman MP; Stredny CM; Asiri A; Hundallah K; Doja A; Payne E; Wirrell E; Koh S; Carpenter JL; Riviello J
    Ann Clin Transl Neurol; 2020 Dec; 7(12):2467-2474. PubMed ID: 33506622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol in the acute phase of febrile infection-related epilepsy syndrome (FIRES).
    Fetta A; Crotti E; Campostrini E; Bergonzini L; Cesaroni CA; Conti F; Di Pisa V; Gentile V; Mondardini MC; Vezzoli C; Giordano L; Cordelli DM
    Epilepsia Open; 2023 Jun; 8(2):685-691. PubMed ID: 37042946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagus nerve stimulation for super-refractory status epilepticus in febrile infection-related epilepsy syndrome: a pediatric case report and literature review.
    Luo T; Wang Y; Lu G; Zhou Y; Wang Y
    Childs Nerv Syst; 2022 Jul; 38(7):1401-1404. PubMed ID: 34762158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.
    Gofshteyn JS; Wilfong A; Devinsky O; Bluvstein J; Charuta J; Ciliberto MA; Laux L; Marsh ED
    J Child Neurol; 2017 Jan; 32(1):35-40. PubMed ID: 27655472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
    Caputo D; Iorio R; Vigevano F; Fusco L
    Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.
    Specchio N; Pietrafusa N
    Dev Med Child Neurol; 2020 Aug; 62(8):897-905. PubMed ID: 32372459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment of Pediatric FIRES With Anakinra.
    Yang JH; Nataraj S; Sattar S
    Pediatr Neurol; 2021 Jan; 114():60-61. PubMed ID: 33227629
    [No Abstract]   [Full Text] [Related]  

  • 18. Febrile infection-related epilepsy syndrome treated with anakinra.
    Kenney-Jung DL; Vezzani A; Kahoud RJ; LaFrance-Corey RG; Ho ML; Muskardin TW; Wirrell EC; Howe CL; Payne ET
    Ann Neurol; 2016 Dec; 80(6):939-945. PubMed ID: 27770579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus.
    Kothur K; Bandodkar S; Wienholt L; Chu S; Pope A; Gill D; Dale RC
    Epilepsia; 2019 Aug; 60(8):1678-1688. PubMed ID: 31283843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febrile Infection-Related Epilepsy Syndrome Treated Successfully With Anakinra in a 21-Year-Old Woman.
    Westbrook C; Subramaniam T; Seagren RM; Tarula E; Co D; Furstenberg-Knauff M; Wallace A; Hsu D; Payne E
    WMJ; 2019 Oct; 118(3):135-139. PubMed ID: 31682750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.